Skip to main content
. 2023 Oct 17;13:1244341. doi: 10.3389/fonc.2023.1244341

Figure 4.

Figure 4

Forest plot of the subgroup analyses for overall survival. HR, hazard ratio; CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group Performance Status; ALBI, albumin-bilirubin; AFP, a-fetoprotein; T+L+C, transarterial chemoembolization combined with lenvatinib plus camrelizumab; T+C, transarterial chemoembolization combined with camrelizumab.